期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

抗精神病药物的药物遗传学研究进展

暂未订购
导出
摘要 抗精神病药物是精神分裂症的主要治疗手段，其在使用过程中经常出现个体的药效差异及不良反应。药物遗传学提供了实现个体化用药的可能。本文查阅近期文献，特别对神经递质受体及肝药酶的基因多态性进行总结，讨论药物遗传学与抗精神病药物的关系，结果显示，部分的基因多态性与药物的疗效有关，但是还需要更多的研究来支持。
作者 陈彬彬 章家新
机构地区 厦门市仙岳医院
出处 《中国民康医学》 2013年第9期66-69,共4页 Medical Journal of Chinese People’s Health
关键词 抗精神病药物 药物遗传学 多态性
分类号 R971.4 [医药卫生—药品]
  • 相关文献

参考文献31

  • 1LENCZ T, ROBINSON DG, XU K, et al. DRD2 promoter regionvariation as a predictor of sustained response to antipsychotic medi-cation in first - episode schizophrenia patients[ J] . The Americanjournal of psychiatry, 2006,163(3) : 529 -531.
  • 2WU S, XING Q, GAO R, et al. Response to chlorpromazine treat-ment may be associated with polymorphisms of the DRD2 gene inChinese schizophrenic patients [ J]. Neuroscience letters,2005,376(1) : 1 -4.
  • 3ZHANG J P,TODD LENCZ, ANIL K. MALHOTRA. DopamineD2 receptor genetic variation and clinical response to antipsychoticdrug treatment: A meta - analysis [ J]. The American journal ofpsychiatry, 2010, 167(7) : 763 -772.
  • 4WILFFERT B,ZAAL R, BROUWERS JR. Pharmacogenetics as atool in the therapy of schizophrenia [ J]. pharmacy world and sci-ence’2005’ 27(1): 20 -30.
  • 5SHEN YC,CHEN SF, CHEN CH, et al. Effects of DRD2/ANKK1 gene variations and clinical factors on aripiprazole efficacyin schizophrenic patients [ J]. Journal of psychiatric research,2009,43(6) : 600-606.
  • 6HWANG H, SHINKAI T, DELUCA V,et al. Association study of12 polymorphisms spanning the dopamine D ( 2) receptor gene andclozapine treatment response in two treatment refractory/ intolerantpopulations [J] . Psychopharmacology ( Berl) ,2005 , 181(1) : 179-187.
  • 7VIJAYAN NN, BHASKARAN S, KOSHY LV, et al. Associationof dopamine receptor polymorphisms with schizophrenia and antip-sychotic response in a South Indian population [ J]. Behavioral andBrain Function, 2007,3 : 34 -46.
  • 8IKEDA M, YAMANOUCHI Y, KINOSHITA Y,et al. Variants ofdopamine and serotonin candidate genes as predictors of response torisperidone treatment in first — episode schizophrenia[ J]. Pharma-cogenomics,2008, 9( 10) : 1437 - 1443.
  • 9LANE HY, LEE CC, CHANG YC, et al. Effects of dopamine D2receptor Ser311 Cys polymorphism and clinical factors on risperi-done efficacy for positive and negative symptoms and social function[J]. The International Journal of Neuropsychopharmacology,2004, 7(4) : 461 -70.
  • 10ITOKAWA M, ARINAMI T, TORU M. Advanced research ondopamine signaling to develop drugs for the treatment of mentaldisorders : Ser311 Cys polymorphisms of the dopamine D2 - recep-tor gene and schizophrenia [ J]. Journal of Pharmacological Sci-ences,2010, 114(1) :1 -5.
中国民康医学
2013年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部